Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$14M Buy
2,571,227
+14,846
+0.6% +$87.6K 0.74% 18
2023
Q2
$14M Sell
2,556,381
-96,996
-4% -$531K 0.57% 20
2023
Q1
$14.9M Buy
2,653,377
+78,915
+3% +$421K 0.66% 20
2022
Q4
$14.2M Sell
2,574,462
-78,266
-3% -$457K 0.8% 18
2022
Q3
$16M Buy
2,652,728
+72,458
+3% +$494K 0.79% 19
2022
Q2
$16.7M Buy
+2,580,270
New +$18.6M 0.94% 17
2021
Q4
Sell
-5,545,179
Closed -$56.6M 28
2021
Q3
$56.6M Buy
+5,545,179
New +$55.4M 1.27% 20

Other funds holding RNW

Sylebra Capital (HK)'s RNW Position: Q3 2023 in Review

Sylebra Capital (HK) increased its ReNew (RNW) stake by 0.58% in Q3 2023, buying an estimated $87.6K and bringing the position to 2,571,227 shares worth $14M. The position accounts for 0.74% of the portfolio, ranked #18.

Sylebra Capital (HK) first reported a position in RNW in Q3 2021 and has held it in 7 quarters since. The position peaked at $56.6M in Q3 2021. 78 funds tracked by Wall St. Rank hold RNW as of Q3 2023.

  • Sylebra Capital (HK) held 2,571,227 shares of ReNew worth $14M as of Q3 2023.
  • Sylebra Capital (HK) bought 14,846 ReNew shares in Q3 2023, an estimated $87.6K.
  • ReNew made up 0.74% of Sylebra Capital (HK)'s portfolio in Q3 2023, its #18 holding.
  • Sylebra Capital (HK) first reported a position in ReNew in Q3 2021 and has held it in 7 quarters since.
  • Sylebra Capital (HK)'s ReNew position peaked at $56.6M in Q3 2021.
  • 78 funds tracked by Wall St. Rank held ReNew as of Q3 2023.

Based on Sylebra Capital (HK)'s 13F filing for Q3 2023, filed 15 Nov 2023.